Standout Papers
- GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes (2017)
- The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial (2019)
- Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial (2016)
Citation Impact
4 from Science/Nature 68 standout
Citing Papers
Adipose tissue retains an epigenetic memory of obesity after weight loss
2024 StandoutNature
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
2024 Standout
Works of Mark H.H. Kramer being referenced
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes
2017 Standout
Practical diagnostic management of patients with clinically suspected deep vein thrombosis by clinical probability test, compression ultrasonography, and D-dimer test
2002
Author Peers
| Author | EDM | Surgery | CCM | Epidemiology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Mark H.H. Kramer | 2014 | 1429 | 646 | 796 | 151 | 5.6k | |
| Y. Sakisaka | 6 | 1 | 1 | 88 | 1.7k | ||
| Stefania Bucci | 5 | 6 | 2 | 25 | 30 | 613 | |
| Andrew M. Diaz | 4 | 44 | 24 | 13 | 360 | ||
| Kwang‐Yul Cha | 17 | 107 | 7 | 26 | 29 | 1.7k | |
| Piotr Stalke | 5 | 58 | 6 | 174 | 42 | 319 |
All Works
Login with ORCID to disown or claim papers
Loading papers...